Global Mental Health Summit and Workshops
WORKSHOP PROGRAM FOR FRIDAY DECEMBER 12th, 2025
Sessions on Friday, December 12th, 2025 Workshop Breakout 2nd Floor Room 21
10:30 -12:00 PM Workshop 1 breakout 2nd Floor Room 21:
Panel Speakers: Psychedelics VC, Home Office and PPM, Securities and IPs. (TBA) Moderated by Margret Luge, Psychedelics Insight Moderator of 2025-2030, Prospective Mental Health product development investment, Ibogaine & Psychedelics Portfolios. Panel Speakers: Psychedelics VC, Home Office, and PPM, Securities, and IPs. (TBA)
1:00-2:30 AM Workshop 2 Breakout 2nd Floor Room 21
Moderated by W. Bryan Hubbard, Mental Health Security Fund and Ibogaine Consortium (TBA) Creating a Private Public Sector Partnership in Ibogaine Clinical Research in NYS, TX, and USA – Global Private Public Sector Partnership on the Ibogaine Access for Benefit Sharing Moderated by Bryant Hubbard, Ibogaine for Americans
2;30- 4:00 pm Workshop 3: Breakout 2nd Floor Room 21
Moderated by Commissioner Sullivan, Mental Health (TBA) Investing in Private Public Sector Partnership and Consortium Structure for Bipartisan Ibogaine Research Act & Policy Roundtable with Dr. Chinazo Cunningham of the Commission (TBA),
Reporting on the Bipartisan Bill with potential matching fund by Global Mental Health Security Fund for the “Ibogaine Research Act” to match Texas in 300 Mn for the OUD/SUD
4:00 – 5:30 pm: Workshop 4 Breakout 2nd Floor Room 21
Panel Speakers: Psychedelics VC, Home Office and PPM, Securities and IPs. (TBA) Moderated by Andrew Romero, Panel Speakers: Psychedelics VC, Home Office, and PPM, Securities, and IPs. (TBA) Prospective Mental Health product development investment, Ibogaine & Psychedelics Portfolios.
Global Psychedelics Therapist Alliance and Global Ibogaine Therapist Alliance
Working Group
Become a facilitators and mental health professionals Join and Signup for the NYS in Action for the Ibogaine Clinical Research Act
Licensed, credentialed, trained Nurses, Integrative medical Professional can conduct medical screening for treatment recommendations. Join the workshop!
Global Psychedelics Therapist Alliance and Global Ibogaine Therapist Alliance.
Join the NYS Global Ibogaine Therapist Alliance
* Request a copy of Ibogaine Therapist Treatment Manual (Download)
Join the Scientific consortium for ibogaine & psychedelic medical research Workshop
* Request a copy of Freedom to Operate Declaration (Download)
Join the Consortium as NGO and Civil Society Action Group
Become a Private Public Sector Partner of Consortium for Ibogaine Clinical Research
Join the Access for Benefit Sharing of Ibogaine IP protection
Background and History of Ibogaine
Ibogaine has demonstrated promise for Opioid and substance use disorders (SUDs), psychotherapy, and personal spiritual growth. NYC as a birth of Manhattan Project, since 1986, Howard Lotsof’s patent initiation for OUD/SUD/AUD/ and others, many ibogaine treatments are conducted “underground” subcultures in unregulated regions and may after 45 years of NYS legislation for Ibogaine, KRFI is entering into a FDA Investigative New Drug with treatments for poly opioid protocols to ensure the safety of the participant. This study arose to fill the Poly drug opioid endemic and bring evidence base collective data on the potential of ibogaine as a treatment option with the global scientific communities and for health equity and mental health treatment policy.